What question did this study set out to answer?

This study aims to evaluate the relationship between fluoroquinolone use and the risk of neurological and neuropsychiatric disorders.

March 28, 2026Open Access

Fluoroquinolone‐Associated Peripheral and Central Nervous System‐Related Disorders: A Large German Claims‐Based Cohort Study

Leer artículo completoexternamente

Puntos clave

This study aims to evaluate the relationship between fluoroquinolone use and the risk of neurological and neuropsychiatric disorders.
Claims-based cohort study design
Analysis of episodes associated with fluoroquinolone prescriptions
Assessment of risk variation by age and gender
Fluoroquinolone use correlates with higher neurological and neuropsychiatric event risk
Increased risk is especially notable within the first 92 days of use
Risk estimates differ across age and gender subgroups

Resumen

FQ episodes were associated with an increased risk for neurological and neuropsychiatric events, especially within the first 92 days after initial dispensing. Risk estimates vary by age and gender subgroups.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Wicherski et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69c7725e8bbfbc51511e2c8f — DOI: https://doi.org/10.1111/ene.70585

Authors

Julia Wicherski

Jonas Peltner

Cornelia Becker

Journals

European Journal of Neurology

Actions

Institutions

University of Bonn

University of Freiburg

German Center for Neurodegenerative Diseases

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Fluoroquinolone‐Associated Peripheral and Central Nervous System‐Related Disorders: A Large German Claims‐Based Cohort Study

Puntos clave

Resumen

Citation Network

Connected Papers

Discussion

Cite this study

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion